85 related articles for article (PubMed ID: 21216833)
1. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
2. Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial.
Böhm M; Robertson M; Borer J; Ford I; Komajda M; Mahfoud F; Ewen S; Swedberg K; Tavazzi L
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873681
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.
Mentz RJ; Mulder H; Mosterd A; Sweitzer NK; Senni M; Butler J; Ezekowitz JA; Lam CSP; Pieske B; Ponikowski P; Voors AA; Anstrom KJ; Armstrong PW; O'connor CM; Hernandez AF;
J Card Fail; 2021 Jun; ():. PubMed ID: 34217593
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model.
Mentz RJ; Mulder H; Mosterd A; Sweitzer NK; Senni M; Butler J; Ezekowitz JA; Lam CSP; Pieske B; Ponikowski P; Voors AA; Anstrom KJ; Armstrong PW; O'Connor CM;
J Card Fail; 2021 May; ():. PubMed ID: 34216757
[TBL] [Abstract][Full Text] [Related]
5. Remote management of worsening heart failure to avoid hospitalization in a real-world setting.
Ploux S; Strik M; Ramirez FD; Buliard S; Chauvel R; Dos Santos P; Haïssaguerre M; Jobbé-Duval A; Picard F; Riocreux C; Eschalier R; Bordachar P
ESC Heart Fail; 2023 Dec; 10(6):3637-3645. PubMed ID: 37797957
[TBL] [Abstract][Full Text] [Related]
6. Circulating Osteoprotegerin Levels Independently Predict All-cause Mortality in Patients with Chronic Kidney Disease: a Meta-analysis.
Huang QX; Li JB; Huang XW; Jiang LP; Huang L; An HW; Yang WQ; Pang J; Li YL; Huang FX
Int J Med Sci; 2019; 16(10):1328-1337. PubMed ID: 31692972
[No Abstract] [Full Text] [Related]
7. Triceps skinfold as a prognostic predictor in outpatient heart failure.
Zuchinali P; Souza GC; Alves FD; d'Almeida KS; Goldraich LA; Clausell NO; Rohde LE
Arq Bras Cardiol; 2013 Nov; 101(5):434-41. PubMed ID: 24029960
[TBL] [Abstract][Full Text] [Related]
8. Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy.
Truby LK; Regan JA; Giamberardino SN; Ilkayeva O; Bain J; Newgard CB; O'Connor CM; Felker GM; Kraus WE; McGarrah RW; Shah SH
Cardiovasc Diabetol; 2021 Aug; 20(1):161. PubMed ID: 34344360
[TBL] [Abstract][Full Text] [Related]
9. Common Variants on
Gui H; Tang WHW; Francke S; Li J; She R; Bazeley P; Pereira NL; Adams K; Luzum JA; Connolly TM; Hernandez AF; McNaughton CD; Williams LK; Lanfear DE
Circ Heart Fail; 2023 Sep; 16(9):e010438. PubMed ID: 37725680
[TBL] [Abstract][Full Text] [Related]
10. The different risk of new-onset, chronic, worsening, and advanced heart failure: A systematic review and meta-regression analysis.
Shakoor A; Abou Kamar S; Malgie J; Kardys I; Schaap J; de Boer RA; van Mieghem NM; van der Boon RMA; Brugts JJ
Eur J Heart Fail; 2024 Feb; 26(2):216-229. PubMed ID: 37823229
[TBL] [Abstract][Full Text] [Related]
11. New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events.
Lavalle C; Di Lullo L; Jabbour JP; Palombi M; Trivigno S; Mariani MV; Summaria F; Severino P; Badagliacca R; Miraldi F; Bellasi A; Vizza CD
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002571
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine use and mortality in chronic heart failure.
Ribeirinho-Soares P; Madureira S; Elias C; Gouveia R; Neves A; Amorim M; Carreira MS; Pereira J; Almeida J; Lourenço P
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 36916509
[TBL] [Abstract][Full Text] [Related]
13. Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System.
Leung CJ; Bhatt AS; Go AS; Parikh RV; Garcia EA; LE KC; Low D; Allen AR; Fitzpatrick JK; Adatya S; Sax DR; Goyal P; Varshney AS; Sandhu AT; Gustafson SE; Ambrosy AP
J Card Fail; 2024 Apr; ():. PubMed ID: 38697466
[TBL] [Abstract][Full Text] [Related]
14. Worsening heart failure: a concept in evolution.
Puthenpura M; Wilcox J; Tang WHW
Curr Opin Cardiol; 2024 Mar; 39(2):119-127. PubMed ID: 38116785
[TBL] [Abstract][Full Text] [Related]
15. Heart failure--concepts and significance. Birth of a prognostic model.
Sinescu C; Axente L
J Med Life; 2010; 3(4):421-9. PubMed ID: 21254742
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological Sex Differences in Heart Failure Progression After Acute Coronary Syndrome: Insights From the EXAMINE Trial.
Razaghizad A; Aziz H; Zhang GK; Ferreira JP; White WB; Mehta CR; Bakris GL; Zannad F; Sharma A
J Card Fail; 2023 Nov; ():. PubMed ID: 37939897
[TBL] [Abstract][Full Text] [Related]
17. WHF Roadmap on Secondary Prevention of CVD.
Wood DA
Glob Heart; 2024; 19(1):9. PubMed ID: 38273997
[No Abstract] [Full Text] [Related]
18. Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.
Beggs SAS; Jhund PS; McMurray JJV
Eur Heart J; 2018 Oct; ():. PubMed ID: 30357375
[No Abstract] [Full Text] [Related]
19. Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study.
Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Ma SK; Oh KH; Lee KB; Jeong JC; Jung JY; Kim SW;
Sci Rep; 2024 Feb; 14(1):4136. PubMed ID: 38374135
[TBL] [Abstract][Full Text] [Related]
20. Bad players in AL amyloidosis in the current era of treatment.
Kreiniz N; Gertz MA
Expert Rev Hematol; 2023 Jan; 16(1):33-49. PubMed ID: 36620914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
